Concepedia

C. P. Anglin

CP

Statistics

Publications

11

Citations

237

H-Index

11

Active since

1988

Affiliations

Pfizer (United States)(Current)

Sears Holdings (United States)

Skin Research Center

Arie Crown Hebrew Day School

Knowledge Systems Institute

C. P. Anglin is an author at Pfizer (United States) specializing in pharmacology, leukotriene pharmacology, and pharmacodynamics.

Publications per year

1988–2010

11

Publications

11

Identification of fibronectin neoepitopes present in human osteoarthritic cartilage

Marc D. Zack, Elizabeth C. Arner, C. P. Anglin et al. · Arthritis & Rheumatism · 2006 · 49 citations

Medicine, Pathobiology, Pathology +17

Substrate-Dependent Inhibition Kinetics of an Active Site-Directed Inhibitor of ADAMTS-4 (Aggrecanase 1)

Arthur J. Wittwer, Robert L. Hills, Robert H. Keith et al. · Biochemistry · 2007 · 35 citations

Life Sciences, Molecular Biology, Enzymology +16

Protein geranylgeranylation controls collagenase expression in osteoarthritic cartilage

Francis M. Sverdrup, Matthew Yates, Lillian Vickery et al. · Osteoarthritis and Cartilage · 2010 · 25 citations

Dentistry, Molecular Biology, Molecular Medicine +14

Antiinflammatory effects of second-generation leukotriene B4 receptor antagonist, SC-53228: Impact upon Leukotriene B4- and 12(R)-HETE- mediated events

D. J. Fretland, C. P. Anglin, Meire Bremer et al. · Inflammation · 1995 · 22 citations

Medicine, Immunology, Pharmacology +15

Synthesis and pharmacological activity of SC-53228, a leukotriene B4 receptor antagonist with high intrinsic potency and selectivity

Stevan W. Djurić, Stephen H. Docter, Stella S. Yu et al. · Bioorganic & Medicinal Chemistry Letters · 1994 · 19 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10

1–5 of 11